This inventor holds 3 USPTO granted patents. Top assignee: Transgene S.a.. Active years: 1998.
Location History:
- Mundelsheim, FR (1998)
- Mundolsheim, FR (1998)
Company Filing History:
Years Active: 1998
Title: Paul Tolstoshev: Innovator in Biotechnology
Introduction
Paul Tolstoshev is a notable inventor based in Mundelsheim, France. He has made significant contributions to the field of biotechnology, particularly in the development of vectors for cloning and the preparation of hirudin.
Latest Patents
Tolstoshev holds 3 patents, with his latest inventions focusing on advanced biotechnological processes. One of his notable patents involves vectors for cloning hirudin or its analogs. This invention is characterized by the inclusion of a gene that encodes hirudin, along with the necessary elements for gene expression in host cells. The coding gene begins with specific codons, which are crucial for the proper functioning of the process. Another significant patent pertains to vectors designed for the expression and secretion of hirudin by transformed yeasts. This functional block of DNA enables the preparation of hirudin from yeast, incorporating the gene of hirudin and a DNA sequence that facilitates transcription by the yeast.
Career Highlights
Tolstoshev is associated with Transgene S.A., a company that focuses on innovative biopharmaceutical solutions. His work has been instrumental in advancing the understanding and application of hirudin in medical and research settings.
Collaborations
Throughout his career, Tolstoshev has collaborated with esteemed colleagues such as Jean-Pierre Lecocq and Richard Harvey. These partnerships have contributed to the successful development of his patented technologies.
Conclusion
Paul Tolstoshev's contributions to biotechnology, particularly in the area of hirudin research, highlight his role as an influential inventor. His patents reflect a commitment to innovation and the advancement of biopharmaceutical applications.